Cysteine-Mediated Decyanation of Vitamin B12 by the Predicted Membrane Transporter Btum

Total Page:16

File Type:pdf, Size:1020Kb

Cysteine-Mediated Decyanation of Vitamin B12 by the Predicted Membrane Transporter Btum ARTICLE DOI: 10.1038/s41467-018-05441-9 OPEN Cysteine-mediated decyanation of vitamin B12 by the predicted membrane transporter BtuM S. Rempel 1, E. Colucci 1, J.W. de Gier 2, A. Guskov 1 & D.J. Slotboom 1,3 Uptake of vitamin B12 is essential for many prokaryotes, but in most cases the membrane proteins involved are yet to be identified. We present the biochemical characterization and high-resolution crystal structure of BtuM, a predicted bacterial vitamin B12 uptake system. 1234567890():,; BtuM binds vitamin B12 in its base-off conformation, with a cysteine residue as axial ligand of the corrin cobalt ion. Spectroscopic analysis indicates that the unusual thiolate coordination allows for decyanation of vitamin B12. Chemical modification of the substrate is a property other characterized vitamin B12-transport proteins do not exhibit. 1 Groningen Biomolecular and Biotechnology Institute (GBB), University of Groningen, Nijenborgh 4, 9474 AG Groningen, The Netherlands. 2 Department of Biochemistry and Biophysics, Stockholm University, 10691 Stockholm, Sweden. 3 Zernike Institute for Advanced Materials, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands. Correspondence and requests for materials should be addressed to D.J.S. (email: [email protected]) NATURE COMMUNICATIONS | (2018) 9:3038 | DOI: 10.1038/s41467-018-05441-9 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05441-9 fi obalamin (Cbl) is one of the most complex cofactors well as re nement statistics are summarized in Table 1. BtuMTd C(Supplementary Figure 1a) known, and used by enzymes consists of six transmembrane helices with both termini located catalyzing for instance methyl-group transfer and ribo- on the predicted cytosolic side (Fig. 1c). The amino acid nucleotide reduction reactions1,2. For example, in the methionine sequences of BtuM proteins are not related to any other protein5 synthase MetH, the cofactor is used to transfer a methyl moiety but, surprisingly, BtuMTd resembles the structure of S- onto L-homocysteine to produce L-methionine1,3. Many bacteria components from energy-coupling factor (ECF)-type ABC require Cbl for survival1,2,4,5, but only a small subset of prokar- transporters10 (Supplementary Figure 4 and Supplementary yotic species can produce this molecule de novo, via either an Table 1). In contrast to BtuM proteins, ECF-type ABC trans- aerobic or anaerobic pathway4,5. Roughly two thirds of archaea porters are predominantly found in Gram-positive bacteria. They and eubacteria are Cbl-auxotrophs that rely on uptake of either are multi-subunit complexes consisting of two peripheral Cbl or its precursor cobinamide2,5,6 (Cbi, Fig. 1a, Supplementary ATPases and two transmembrane components (EcfT and S- Figure 1b). Dependence on uptake has probably evolved, because component)10,11. EcfT and the ATPases together form the so- synthesis of Cbl involves roughly 30 different enzymes and is called ECF-module. S-components bind the transported sub- energetically costly. Gram-negative bacteria require the TonB- strate, and dynamically associate with the ECF-module to allow dependent transporter BtuB1 to transport Cbl across the outer substrate translocation10,12–14. Intriguingly, no homologues of membrane (Supplementary Figure 1c). For subsequent transport EcfT could be found in T. denitrificans. In addition, all ABC-type of vitamin B12 across the cytoplasmic membrane, the only ATPases encoded by the organism are predicted to be part of characterized bacterial uptake system is the ABC transporter classical ABC transporters, and not ECF transporters. Therefore, BtuCDF, which is predicted to be present in approximately 50% we conclude that the organism does not encode an ECF-module, 5,7 of Cbl-auxotrophic bacteria . Many Cbl-auxotrophic Gram- and hypothesize that solitary BtuMTd may be responsible for Cbl negative bacteria do not encode BtuCDF, whereas they do contain uptake. This hypothesis is supported by the ability of BtuMTd to BtuB. Metabolic reconstruction and chromosomal context ana- transport vitamin B12 when expressed heterologously in E. coli lyses, e.g. co-localization with the gene for BtuB, have identified ΔFEC. Importantly, E.coli also does not encode an ECF- 11 potential alternative inner membrane vitamin B12 transporters, module , hence BtuMTd cannot interact with a module from 5 one of which is BtuM . BtuM homologues are small membrane the host, and BtuMTd must be able to support Cbl uptake using a proteins of ~22 kDa, and found predominantly in Gram-negative different mechanism than that of ECF transporters10,11. In a few species, distributed mostly over α-, β-, and γ-proteobacteria cases, the biotin-specific S-component BioY15 has also been (Supplementary Data 1). found in organisms lacking an ECF-module and was shown to Here, we sought to characterize the predicted vitamin B12 mediate transport without the need for an ECF-module15. fi transporter BtuM from Thiobacillus denitri cans (BtuMTd). We However, organisms encoding only BioY without an ECF-module 15 show that BtuMTd is involved in transport of Cbl in vivo and we are rare , and in the large majority of organisms BioY is asso- solved its structure to 2 Å resolution. A cobalt–cysteine interac- ciated with an ECF-module11. In contrast, BtuM homologues tion allows for chemical modification of the substrate prior to (apart from one exception) are found exclusively in organisms translocation, which is a rare feature among uptake systems. lacking an ECF-module (Supplementary Data 1). Further experiments, for instance using purified protein Results reconstituted in proteoliposomes, are required to test whether BtuM also catalyses transport in vitro without any additional BtuM supports vitamin B12-dependent growth.Totest Td Td component involved. However, the in vivo assay gives a very experimentally whether BtuM is a potential Cbl-transporter, we Td strong indication that BtuM is a transporter itself, as the protein constructed an Escherichia coli triple knockout strain, E. coli ΔFEC, Td was expressed in a heterologous host that does not contain any based on Cadieux et al.8. In this strain, the gene encoding the Cbl- ECF-module or S-component. Similar in vivo experiments have independent methionine synthase, MetE9, is deleted. The metE been used extensively in the past to identify other transporters (for deletion makes it impossible for E. coli ΔFEC to synthesize instance ref.16) and have the advantage over in vitro assays that methionine, unless it can import Cbl8,9.Inthatcase,L-methionine physiologically relevant conditions are used. can be synthesized using the Cbl-dependent methionine synthase, MetH3,8. E. coli ΔFEC has additional deletions in btuF and btuC, encoding subunits of the endogenous Cbl-transporter BtuCDF7,8. Δ BtuMTd binds cobalamin using cysteine ligation. Close to the Therefore, E. coli FECcannotimportCbl,prohibitingMetH- fi predicted periplasmic surface of BtuMTd, we found well-de ned mediated L-methionine synthesis. Consequently, E. coli ΔFEC can electron density (Supplementary Figure 5) representing a bound grow only if L-methionine is present or if vitamin B12 import is Cbl molecule. The binding mode of Cbl in the crystal structure restored by (heterologous) expression of a Cbl-transport system8. (Fig. 2a) is striking for two reasons. First, the essential Cys80 is The phenotype of E. coli ΔFEC was confirmed in growth assays the α-axial ligand of the cobalt ion. To our knowledge, cobalt (Supplementary Figure 2a). Cells that are not expressing any Cbl- coordination by cysteine has not been observed in any other Cbl- transporter did not exhibit substantial growth in methionine-free binding protein of known structure. Binding of cysteine to cobalt medium, whereas cells complemented with an expression plasmid in a corrinoid has been hypothesized for the mercury methylating for BtuCDF grew readily (Fig. 1b). Cells expressing BtuM had a Td enzyme HgcA17 and observed in a synthetic cyclo-decapeptide, similar growth phenotype, indicating that BtuM is a potential Td but in the latter case the residue replaced the β-ligand18. transporter for vitamin B12 (Fig. 1b). Second, Cbl is bound to BtuMTd in the base-off conformation in which the 5,6-dimethylbenzimidazole moiety does not bind to Crystal structure of BtuMTd bound to vitamin B12. The BtuM the cobalt ion (Fig. 2a). In contrast, at physiological pH the family contains an invariably conserved cysteine residue (Sup- conformation of free Cbl in aqueous solution is base-on with the plementary Figure 3a). In BtuMTd, this cysteine is located at 5,6-dimethylbenzimidazole moiety coordinated to the cobalt ion position 80, and mutation to serine abolishes the ability of the in the α-axial position1 (Fig. 1a). The base-off conformation has protein to complement the E. coli ΔFEC strain (Fig. 1b). To been found only in a subset of Cbl-containing enzymes, but not in investigate the role of the cysteine, we solved a crystal structure at Cbl-binding proteins without enzymatic activity1, such as the 19 2 Å resolution of BtuMTd in complex with Cbl. Data collection as periplasmic substrate-binding protein BtuF , the outer 2 NATURE COMMUNICATIONS | (2018) 9:3038 | DOI: 10.1038/s41467-018-05441-9 | www.nature.com/naturecommunications NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05441-9 ARTICLE a b 0.4 Base-off (AU) 0.3 600 CH N 3 OD 0.2 HO 0.1 P Base-on N CH 0400200 600 800 1000 O 3 O α-axial position Time (min) N + 0.4 N _C80S Td Td N BtuM BtuM N (AU) 0.3 25 kDa 600 OD 0.2 β-axial position 15 kDa CN 0.1 0 200 400 600 800 1000 Time (min) c L5 L5 L3 L3 Out L1 L1 H6 H3 90° H4 H2 H5 H6 H1 L2 H4 In L4 L4 Fig. 1 Function and structure of BtuMTd. a Schematic representation of cobalamin (Cbl) showing the corrinoid ring with the central cobalt ion (red).
Recommended publications
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Vitamin B12) Deficiency in Johanson–Blizzard Syndrome
    European Journal of Clinical Nutrition (2013) 67, 1118 & 2013 Macmillan Publishers Limited All rights reserved 0954-3007/13 www.nature.com/ejcn LETTER TO THE EDITOR Pancytopenia from severe cobalamin (Vitamin B12) deficiency in Johanson–Blizzard syndrome European Journal of Clinical Nutrition (2013) 67, 1118; doi:10.1038/ insufficiency and villous atrophy.3 Defective absorption of ejcn.2013.140; published online 31 July 2013 cobalamin may occur in 40–50% of patients with pancreatic insufficiency,5 exact mechanism(s) remain unclear. Proteolytic degradation of non-intrinsic factor-cobalamin binders has been proposed as the pancreas’ primary role in cobalamin metabolism.6 Johanson–Blizzard syndrome is a rare autosomal recessive Additional studies suggest that adequate bicarbonate is necessary disorder characterized by nasal, auditory and dental abnormalities, for pancreatic proteases to function in the intestinal lumen, and 1 there may be interaction between pancreatic enzymes and bile, and exocrine pancreatic insufficiency. These patients require 5 oral pancreatic enzyme replacement and fat-soluble vitamin affecting R binder degradation and cobalamin absorption. supplements.2 In Johanson–Blizzard syndrome, however, ductular output of fluid and electrolytes is preserved.2 Cobalamin (vitamin B12) is essential for several important enzymatic processes in the body that lead to energy metabolism, As patients with exocrine pancreatic insufficiency are on DNA synthesis and blood cell production. Patients with cobalamin fat-soluble vitamin (A,D, E,K) supplements because of steatorrhea deficiency can develop hematological and neuropsychiatric and risk of malabsorption of these vitamins, the clinicians focus on abnormalities. Absorption of cobalamin is complex. Two distinct monitoring the status of these four vitamins.
    [Show full text]
  • Chemical Tools for Residue-Specific and Secondary Amine Selective Petasis (SASP) Bioconjugation of Peptides and Proteins
    Seton Hall University eRepository @ Seton Hall Seton Hall University Dissertations and Theses (ETDs) Seton Hall University Dissertations and Theses Spring 5-4-2020 Chemical tools for Residue-Specific and Secondary Amine Selective Petasis (SASP) bioconjugation of Peptides and Proteins Yonnette Sim [email protected] Follow this and additional works at: https://scholarship.shu.edu/dissertations Part of the Biochemistry Commons Recommended Citation Sim, Yonnette, "Chemical tools for Residue-Specific and Secondary Amine Selective Petasis (SASP) bioconjugation of Peptides and Proteins" (2020). Seton Hall University Dissertations and Theses (ETDs). 2776. https://scholarship.shu.edu/dissertations/2776 Chemical tools for Residue-Specific and Secondary Amine Selective Petasis (SASP) bioconjugation of Peptides and Proteins A dissertation submitted to Seton Hall University in partial fulfillment for the Doctor of Philosophy Degree By: Yonnette E. Sim May 2020 Department of Chemistry and Biochemistry Seton Hall University South Orange, NJ. 07079 USA © 2020 Yonnette E. Sim DocuSign Envelope ID: 9EF6018D-72DB-4316-B86E-3A103260E910 We certify that we have read this dissertation and in our opinion it is adequate in scientific scope and quality as dissertation for the degree of Doctor of Philosophy Dr. Gregory R. Wiedman Mentor Dr. Monika Raj Co-Mentor (No Longer SHU Faculty) Dr. Joseph Badillo Member of Dissertation Committee Dr. Stephen Kelty Department Chair Seton Hall University I dedicate this thesis to my husband, Ebo, my children Ebony and Ethan for their tremendous love and support & My late parents Rupert and Theresa for their love and wisdom. “The only limit to the height of your achievements is the reach of your dreams and your willingness to work for them” – Michelle Obama i ACKNOWLEDGEMENTS First I would like to express my appreciation and thanks to my research mentor, Dr.
    [Show full text]
  • Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR
    Published OnlineFirst June 26, 2018; DOI: 10.1158/0008-5472.CAN-17-3858 Cancer Tumor Biology and Immunology Research Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma Shiao-Ya Hong1, Yu-Rung Kao1, Te-Chang Lee1, and Cheng-Wen Wu1,2,3,4 Abstract CBLC (CBL proto-oncogene c) belongs to the CBL protein ubiquitinated and positively regulated aEGFR stability family, which has E3 ubiquitin ligase activity toward activated through the conjugation of polyubiquitin by K6 and K11 receptor tyrosine kinases. CBLC is frequently upregulated in linkages. This CBLC-mediated polyubiquitination promoted non–small cell lung cancer (NSCLC), yet very little is known either preferential recycling of aEGFR back to the plasma about the functions of CBLC in tumorigenesis. Here we show membrane or trafficking to the cell nucleus. IHC analyses that CBLC is an epigenetically demethylated target and its revealed a positive correlation between phospho-EGFR and expression can be upregulated in NSCLC after treatment with CBLC in lung adenocarcinoma. In summary, we demonstrate a the DNA methylation inhibitor 50-azacytidine. Depletion novel mechanism by which aEGFR escapes lysosomal degra- of CBLC significantly inhibited cell viability and clonogenicity dation in a CBLC/ubiquitin-dependent manner to sustain its in vitro and reduced tumor growth in a xenograft model. CBLC activation. Our work identifies CBLC as a potential diagnostic silencing further sensitized EGFR-mutated NSCLC cells to biomarker and also points to its utilization as a novel thera- treatment with tyrosine kinase inhibitors. Conversely, ectopic peutic target for NSCLC therapy. expression of CBLC enhanced the activation of EGFR and downstream ERK1/2 signaling after ligand stimulation by Significance: This work demonstrates the role of CBLC expres- competing with CBL for EGFR binding.
    [Show full text]
  • The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus
    Syracuse University SURFACE Chemistry - Dissertations College of Arts and Sciences 12-2012 The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus Susan Clardy James Syracuse University Follow this and additional works at: https://surface.syr.edu/che_etd Part of the Chemistry Commons Recommended Citation James, Susan Clardy, "The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus" (2012). Chemistry - Dissertations. 196. https://surface.syr.edu/che_etd/196 This Dissertation is brought to you for free and open access by the College of Arts and Sciences at SURFACE. It has been accepted for inclusion in Chemistry - Dissertations by an authorized administrator of SURFACE. For more information, please contact [email protected]. Abstract Protein therapeutics like insulin and glucagon-like peptide-1 analogues are currently used as injectable medications for the treatment of diabetes mellitus. An orally administered protein therapeutic is predicted to increase patient adherence to medication and bring a patient closer to metabolic norms through direct effects on hepatic glucose production. The major problem facing oral delivery of protein therapeutics is gastrointestinal tract hydrolysis/proteolysis and the inability to passage the enterocyte. Herein we report the potential use of vitamin B12 for the oral delivery of protein therapeutics. We first investigated the ability of insulin to accommodate the attachment of B12 at the B1 vs. B29 amino acid position. The insulinotropic profile of both conjugates was evaluated in streptozotocin induced diabetic rats. Oral administration of the conjugates produced significant drops in blood glucose levels, compared to an orally administered insulin control, but no significant difference was observed between conjugates.
    [Show full text]
  • Downloaded from the App Store and Nucleobase, Nucleotide and Nucleic Acid Metabolism 7 Google Play
    Hoytema van Konijnenburg et al. Orphanet J Rare Dis (2021) 16:170 https://doi.org/10.1186/s13023-021-01727-2 REVIEW Open Access Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app Eva M. M. Hoytema van Konijnenburg1†, Saskia B. Wortmann2,3,4†, Marina J. Koelewijn2, Laura A. Tseng1,4, Roderick Houben6, Sylvia Stöckler‑Ipsiroglu5, Carlos R. Ferreira7 and Clara D. M. van Karnebeek1,2,4,8* Abstract Background: The Treatable ID App was created in 2012 as digital tool to improve early recognition and intervention for treatable inherited metabolic disorders (IMDs) presenting with global developmental delay and intellectual disabil‑ ity (collectively ‘treatable IDs’). Our aim is to update the 2012 review on treatable IDs and App to capture the advances made in the identifcation of new IMDs along with increased pathophysiological insights catalyzing therapeutic development and implementation. Methods: Two independent reviewers queried PubMed, OMIM and Orphanet databases to reassess all previously included disorders and therapies and to identify all reports on Treatable IDs published between 2012 and 2021. These were included if listed in the International Classifcation of IMDs (ICIMD) and presenting with ID as a major feature, and if published evidence for a therapeutic intervention improving ID primary and/or secondary outcomes is avail‑ able. Data on clinical symptoms, diagnostic testing, treatment strategies, efects on outcomes, and evidence levels were extracted and evaluated by the reviewers and external experts. The generated knowledge was translated into a diagnostic algorithm and updated version of the App with novel features. Results: Our review identifed 116 treatable IDs (139 genes), of which 44 newly identifed, belonging to 17 ICIMD categories.
    [Show full text]
  • An X-Linked Cobalamin Disorder Caused by Mutations in Transcriptional Coregulator HCFC1
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector ARTICLE An X-Linked Cobalamin Disorder Caused by Mutations in Transcriptional Coregulator HCFC1 Hung-Chun Yu,1 Jennifer L. Sloan,2 Gunter Scharer,1,3,4,9 Alison Brebner,5 Anita M. Quintana,1 Nathan P. Achilly,2 Irini Manoli,2 Curtis R. Coughlin II,1,3 Elizabeth A. Geiger,1 Una Schneck,1 David Watkins,5 Terttu Suormala,6,7 Johan L.K. Van Hove,1,3 Brian Fowler,6,7 Matthias R. Baumgartner,6,7,8 David S. Rosenblatt,5 Charles P. Venditti,2 and Tamim H. Shaikh1,3,4,* Derivatives of vitamin B12 (cobalamin) are essential cofactors for enzymes required in intermediary metabolism. Defects in cobalamin metabolism lead to disorders characterized by the accumulation of methylmalonic acid and/or homocysteine in blood and urine. The most common inborn error of cobalamin metabolism, combined methylmalonic acidemia and hyperhomocysteinemia, cblC type, is caused by mutations in MMACHC. However, several individuals with presumed cblC based on cellular and biochemical analysis do not have mutations in MMACHC. We used exome sequencing to identify the genetic basis of an X-linked form of combined methylmalonic acidemia and hyperhomocysteinemia, designated cblX. A missense mutation in a global transcriptional coregulator, HCFC1, was identi- fied in the index case. Additional male subjects were ascertained through two international diagnostic laboratories, and 13/17 had one of five distinct missense mutations affecting three highly conserved amino acids within the HCFC1 kelch domain. A common phenotype of severe neurological symptoms including intractable epilepsy and profound neurocognitive impairment, along with variable biochemical manifestations, was observed in all affected subjects compared to individuals with early-onset cblC.
    [Show full text]
  • Heme Uptake in Lactobacillus Sakei Evidenced by a New ECF-Like Transport System
    bioRxiv preprint doi: https://doi.org/10.1101/864751; this version posted December 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 1 Title: Heme uptake in Lactobacillus sakei evidenced by a new ECF-like transport system. 2 3 Emilie Verplaetse1, Gwenaëlle André-Leroux2, Philippe Duhutrel1,3, Gwendoline Coeuret1, 4 Stéphane Chaillou1, Christina Nielsen-Leroux1, Marie-Christine Champomier-Vergès1* 5 1) Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, 78350 Jouy-en- 6 Josas, France. 7 2) Université Paris-Saclay, INRAE, MaIAGE, 78350 Jouy-en-Josas, France. 8 3) Present address: bioMérieux, 5 rue des Aqueducs, 69290 Craponne, France. 9 10 11 12 13 Running title: heme transport in Lactobacillus sakei 14 15 *Corresponding author: [email protected] 16 17 Key-words: iron, lactic acid bacteria, ABC-transporter 18 bioRxiv preprint doi: https://doi.org/10.1101/864751; this version posted December 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 19 Abstract 20 Lactobacillus sakei is a non-pathogenic lactic acid bacterium and a natural inhabitant of meat 21 ecosystems. Although red meat is a heme-rich environment, L. sakei does not need iron or 22 heme for growth, while possessing a heme-dependent catalase. Iron incorporation into L. 23 sakei from myoglobin and hemoglobin was formerly shown by microscopy and the L. sakei 24 genome reveals a complete equipment for iron and heme transport.
    [Show full text]
  • Vitamin B12 Testing
    Vitamin B12 testing Dr Zhong X Lu MBBS, MAACB, MHN, FRCPA, PhD Chemical Pathologist Melbourne Pathology & Monash Pathology [email protected] Tel: 9287 7720 Topics ‣ B12 physiology ‣ Total B12 (TB12) and Holo-transcobalamin (HoloTC) ‣ Different binding proteins in blood for B12 ‣ Laboratory assessment for B12 status ‣ TB12 vs HoloTC assays: ‣ Questions: Are all the TB12 assays the same? ‣ Functional markers: ‣ homocysteine (HCY); methyl-malonic acid (MMA) ‣ FBE: Hb, MCV, film ‣ Questions to cover: ‣ 1. Is the HoloTC assay better test than the TB12 assays? ‣ 2. What is an equivocal range for TB12 assays? ‣ 3. How do we interpret the HoloTC results? Vitamin B12 ‣ Rich sources: ‣ Meat, egg, milk and dairy ‣ Recommended Daily Allowance (RDA): ‣ Adult: 2 ug/day ‣ Pregnancy & lactation: 2.6 ug/day ‣ Toddler-Children: 0.7 - 2 ug/day ‣ Western diet: ‣ Average 3-30 ug/day, 1-5 ug/day absorbed ‣ Total body store: ‣ 2 - 5 mg (50% in liver) ‣ Takes many years to deplete without intake B12 absorption In food: B12-binds to animal protein In Stomach and proximal SI: • B12 is cleaved off from the food binding protein • B12–Intrinsic factor complex formed • B12-IF transported to ileum In distal ileum (80 cm): • B12-IF complex bound to IF receptor • B12 absorbed into blood Andrès E et al. CMAJ 2004; 171: 251-259 B12 Binding Protein in Blood ~ 75% ~25% Total B12 influenced by changes in binding proteins → poor indicator of bioavailable cobalamin Metabolic Functions of B12: a cofactor of Methionine Synthase In B12 deficiency HoloTC ↑ Homocysteine X ↑ MMA X Methyl Malonic Acid Mutase Topics ‣ B12 physiology ‣ – Total B12 (TB12) and Holo-transcobalamin (HoloTC) ‣ Different binding proteins in blood for B12 ‣ Laboratory assessment for B12 status ‣ TB12 vs HoloTC assays: ‣ Questions: Are all the TB12 assays the same? ‣ Functional markers: ‣ homocysteine (HCY); methyl-malonic acid (MMA) ‣ FBE: Hb, MCV, film ‣ Questions to cover: ‣ 1.
    [Show full text]
  • Synthesis and Characterization of Doxorubicin Carrying Cetuximab-Pamam Dendrimer Bioconjugates
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2012 SYNTHESIS AND CHARACTERIZATION OF DOXORUBICIN CARRYING CETUXIMAB-PAMAM DENDRIMER BIOCONJUGATES GUNJAN SAXENA Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Biomedical Engineering and Bioengineering Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2788 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Gunjan Saxena 2012 All Rights Reserved SYNTHESIS AND CHARACTERIZATION OF DOXORUBICIN CARRYING CETUXIMAB- PAMAM DENDRIMER BIOCONJUGATES A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Biomedical Engineering at Virginia Commonwealth University By Gunjan Saxena Bachelor of Engineering, Rajiv Gandhi Technological Institute, India, 2008 Director: Dr. Hu Yang, Ph.D., Associate Professor, Biomedical Engineering Virginia Commonwealth University Richmond, Virginia May 2012 ii Acknowledgement To my parents - Every bit of me is a little bit of you. This thesis is dedicated to my father, Nawal Saxena, who taught me that the best kind of knowledge to have is that which is learned for its own sake. It is also dedicated to my mother, Preety Saxena, who taught me to dream big and that even the largest task can be accomplished if it is done one step at a time. I am most grateful to them and my sister, Nikita Saxena, for having faith in me.
    [Show full text]
  • A Graph-Theoretic Approach to Model Genomic Data and Identify Biological Modules Asscociated with Cancer Outcomes
    A Graph-Theoretic Approach to Model Genomic Data and Identify Biological Modules Asscociated with Cancer Outcomes Deanna Petrochilos A dissertation presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2013 Reading Committee: Neil Abernethy, Chair John Gennari, Ali Shojaie Program Authorized to Offer Degree: Biomedical Informatics and Health Education UMI Number: 3588836 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMI 3588836 Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, MI 48106 - 1346 ©Copyright 2013 Deanna Petrochilos University of Washington Abstract Using Graph-Based Methods to Integrate and Analyze Cancer Genomic Data Deanna Petrochilos Chair of the Supervisory Committee: Assistant Professor Neil Abernethy Biomedical Informatics and Health Education Studies of the genetic basis of complex disease present statistical and methodological challenges in the discovery of reliable and high-confidence genes that reveal biological phenomena underlying the etiology of disease or gene signatures prognostic of disease outcomes. This dissertation examines the capacity of graph-theoretical methods to model and analyze genomic information and thus facilitate using prior knowledge to create a more discrete and functionally relevant feature space.
    [Show full text]
  • Structural and Functional Characterisation of the Cobalamin Transport Protein Haptocorrin
    Research Collection Doctoral Thesis Structural and functional characterisation of the cobalamin transport protein haptocorrin Author(s): Furger, Evelyne Publication Date: 2012 Permanent Link: https://doi.org/10.3929/ethz-a-007608480 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS ETH 20838 Structural and Functional Characterisation of the Cobalamin Transport Protein Haptocorrin A dissertation submitted to ETH ZURICH for the degree of DOCTOR OF SCIENCES Presented by EVELYNE FURGER MSc ETH Pharm. Sci. Born 25.04.1981 Citizen of Silenen UR Accepted on the recommendation of Prof. Dr. Roger Schibli, examiner Prof. Dr. Ebba Nexø, co-examiner Prof. Dr. Simon M. Ametamey, co-examiner 2012 To my parents Acknowledgements I would like to express my gratitude to all those who supported me to complete this thesis. First and foremost, I owe my deepest gratitude to my supervisor Dr. Eliane Fischer whose help, encouragement and stimulating enthusiasm helped me through all the times of the dissertation. Furthermore, I want to thank all my colleagues from the Center of Radiopharmaceutical Sciences at the ETH Zurich and the Paul Scherrer Institute in Villigen for all their help, support and the nice time we spent together inside and outside the lab. I would like to thank Prof. Roger Schibli for giving me the opportunity to perform my doctorate in his group and Prof. Ebba Nexø and Prof. Simon M. Ametamey for being in the committee as co-referees. Finally, I want to express my heartfelt gratitude to my parents Eduard and Marianna, Carmen, Patricia, Thomas, Nicole and all my friends for their never-ending support and care.
    [Show full text]